Ovesco has been able to achieve a large growth in turnover and employees in recent years. Among 12,000 businesses nationwide surveyed by FOCUS-Business, the medical technology company has now been awarded the title of „FOCUS Wachstumschampion 2020“ (FOCUS Growth Champion 2020).
Growth Champions 2020 is a listing of top-500 German businesses that were able to achieve a large percentage increase in revenue between 2015 and 2018 (business magazine FOCUS-Business). The list was compiled and evaluated by the Hamburg Institute Statista. Only companies that are based in Germany, are independent and have high organic growth were considered.
For the final analysis, 1,654 companies from a wide range of industrial and service sectors qualified.
With a consistent annual growth rate of >20% during the four-year observation period, Ovesco entered the top-500 and is even ranked 10th of all companies nationwide in the industry comparison for electronics, electrical engineering, and medical technology.
Two main strategic fields of action contributed to Ovesco’s strong revenue growth: innovation management and the expansion of international sales.
Product innovation is one of Ovesco’s core competencies. Prognos and the F.A.Z.-Institute list Ovesco as one of the innovation leaders in Germany. This again confirms the research strength of the Tuebingen-based company.
Today, Ovesco has locations in Germany, France, the USA and India. Patients are treated with Ovesco-products in more than 70 countries. Internationality is therefore an important characteristic of Ovesco’s corporate culture, which is why since 2019 the company has also been a signatory of the „Charta der Vielfalt” (diversity charter) for diversity in the world of work, which is under the auspices of German Chancellor.